Author Correction: High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy

Carsten Krieg^{1

2}, Malgorzata Nowicka^{3

4}, Silvia Guglietta⁵, Sabrina Schindler⁶, Felix J Hartmann⁷, Lukas M Weber^{3

4}, Reinhard Dummer⁶, Mark D Robinson^{3

4}, Mitchell P Levesque⁸, Burkhard Becher⁹

Affiliations

¹ Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland. kriegc@musc.edu.
² Department of Microbiology and Immunology and Department of Dermatology, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA. kriegc@musc.edu.
³ Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
⁴ Swiss Institute of Bioinformatics (SIB), University of Zurich, Zurich, Switzerland.
⁵ Department of Experimental Oncology, European Institute of Oncology, Milan, Italy.
⁶ Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
⁷ Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
⁸ Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. mitchell.levesque@usz.ch.
⁹ Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland. becher@immunology.uzh.ch.

PMID: 29967347
DOI: 10.1038/s41591-018-0094-7

Published Erratum

Author Correction: High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy

Carsten Krieg et al. Nat Med. 2018 Nov.

. 2018 Nov;24(11):1773-1775.

doi: 10.1038/s41591-018-0094-7.

Authors

Affiliations

¹ Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland. kriegc@musc.edu.
² Department of Microbiology and Immunology and Department of Dermatology, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA. kriegc@musc.edu.
³ Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
⁴ Swiss Institute of Bioinformatics (SIB), University of Zurich, Zurich, Switzerland.
⁵ Department of Experimental Oncology, European Institute of Oncology, Milan, Italy.
⁶ Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
⁷ Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
⁸ Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. mitchell.levesque@usz.ch.
⁹ Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland. becher@immunology.uzh.ch.

PMID: 29967347
DOI: 10.1038/s41591-018-0094-7

Abstract

In the version of this article initially published, Figs. 5a,c and 6a were incorrect because of an error in a metadata spreadsheet that led to the healthy donor patient 2 (HD2) samples being used twice in the analysis of baseline samples and in the analysis at 12 weeks of anti-PD-1 therapy, while HD3 samples had not been used.

PubMed Disclaimer

Erratum for

High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy.
Krieg C, Nowicka M, Guglietta S, Schindler S, Hartmann FJ, Weber LM, Dummer R, Robinson MD, Levesque MP, Becher B. Krieg C, et al. Nat Med. 2018 Feb;24(2):144-153. doi: 10.1038/nm.4466. Epub 2018 Jan 8. Nat Med. 2018. PMID: 29309059

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy

Affiliations

Author Correction: High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy

Authors

Affiliations

Abstract

Erratum for

Publication types

LinkOut - more resources

Full Text Sources

Other Literature Sources